Immunohistochemistry (IHC) Market Landscape 2025: Forecast Data and Growth Strategy Insights

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Immunohistochemistry (IHC) Market Through 2025?
In the last few years, the immunohistochemistry (IHC) market has experienced considerable growth. The market is projected to escalate from $2.58 billion in 2024 to $2.78 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.0%. This growth over the historical period can be traced back to factors like increased clinical adoption, industry standardization, advancements in cancer research, automation in laboratory processes, and improved clinical diagnostics.

What's the Projected Size of the Global Immunohistochemistry (IHC) Market by 2029?
In the forthcoming years, the immunohistochemistry (IHC) market is projected to experience swift expansion. The market is anticipated to escalate to $4.13 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%. The projected growth in this period can be ascribed to the introduction of new competitors, increased demand in the field of drug development, integration of biomedical research, applications in diagnostics, along with advances in automation and digitization. Key trends that will shape the forecast period point towards the adoption of multiplex IHC methods, the integration of digital pathology, improved antibody specificity, the promotion of automation and standardization, and the utilization in biomarker discovery.

View the full report here:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Top Growth Drivers in the Immunohistochemistry (IHC) Industry: What's Accelerating the Market?
The rising occurrence of chronic illnesses is anticipated to spur the growth of the immunohistochemistry (IHC) market in the future. Chronic illnesses involve clinical conditions that persist for at least three months or longer and while they can usually be managed, they typically cannot be cured. Immunohistochemistry aids in the detection of chronic diseases such as cancer, cardiovascular diseases, and others. This is due to the various benefits it offers, including its specificity, sensitivity (used for identifying particular antigens), prompt results, and more. For example, in 2022, data from the Centers for Disease Control and Prevention, a US-based national public health organization, indicated that approximately 37.3 million individuals, equating to 11.3% of the United States population, had diabetes. Therefore, the escalating prevalence of chronic diseases is fueling the expansion of the immunohistochemistry (IHC) market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

What Trends Will Shape the Immunohistochemistry (IHC) Market Through 2029 and Beyond?
Companies that are major players in the immunohistochemistry (IHC) market are concentrating their efforts on improving diagnostic precision by implementing innovative technologies and superior quality reagents. This focus is aimed at boosting the efficiency of tissue examination for diverse clinical and research purposes. The Neoflex multiomics mass spectrometry imaging (MSI) system is a modern platform tailored for meticulous tissue investigation. It facilitates the scientists in the transition from discovery to clinical applicability through sophisticated mass spectrometry methods. These are particularly efficient in the spatial mapping of biomolecules within tissues. For example, in June 2024, Bruker Corporation, an American firm with a specialty in creating and manufacturing scientific apparatus and solutions for analytical and diagnostic purposes, unveiled their MALDI-TOF/TOF Neoflex Imaging Profiler. This equipment is used for tissue imaging based on mass spectrometry. The Neoflex multiomics mass spectrometry imaging (MSI) system meets the demand for transitioning from discovery imaging towards clinical research concerning tissue. The system is equipped with Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors and is compatible with OME-TIFF file output by incorporating SCiLS Scope software.

What Are the Main Segments in the Immunohistochemistry (IHC) Market?
The immunohistochemistry (IHC) market covered in this report is segmented -

1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Which Top Companies are Driving Growth in the Immunohistochemistry (IHC) Market?
Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

Which Regions Will Dominate the Immunohistochemistry (IHC) Market Through 2029?
North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.